Ms. Vanessa Huang

Ms. Vanessa Huang is a member of the WHO Council on the Economics of Health. For All which aims to reframe health for all as a public policy objective. Ms. Huang is currently a General Partner at BVCF Management, a venture capital firm that works with global growth-stage healthcare companies with focus on Greater China. Ms. Huang is a member of the InnoHK Steering Committee which advises the Hong Kong government on the InnoHK research clusters. She is also a member of the Biotech Advisory Panel of the Stock Exchange of Hong Kong and the Admission Panel of the Incu-Bio Incubation Programme of the Hong Kong Science and Technology Parks. Ms. Huang is an independent non-executive director of Alibaba Health Information Technology Limited (HKEX Stock code: 00241). BVCF Management is a co-investment partner of the Hong Kong government’s Innovation and Technology Venture Fund. 

Prior to joining BVCF Management, Ms. Huang was Head of Emerging Asia Healthcare Investment Banking at J.P. Morgan. Before J.P. Morgan, she led Deutsche Bank Asia’s healthcare investment banking coverage. Ms. Huang gained biotech industry experience at Amgen. Ms. Huang obtained a Master of Business Administration from The Wharton School, University of Pennsylvania.